Remote work - Unsplash

C-level Executives are leading by example when it comes to hybrid working, with the vast majority stating that they have personally taken on flexible working arrangements, according to a recent study by International Workplace Group.

The study polled over 500 CEOs in the United Kingdom and brought to light a number of interesting insights about the evolving nature of work, particularly at the executive level.

It found that out of the CEOs questioned, 93 per cent said that they now split their working time across different locations.

Interestingly, just seven per cent said that they spend five days a week working from their company’s office.

This highlights a significant discrepancy between what business leaders do, and what they expect from their workforce.

Following the COVID-19 pandemic, there have been several calls from businesses of different sizes urging their employees to return to the office. Some have struggled as employees have grown accustomed to the flexible working arrangements that they enjoyed during the pandemic, including the likes of Google, Amazon, X, and Zoom.

Seven in 10 companies have changed their policies in favour of a return to office, as employees have become less reluctant to do so. In Australia, companies have also pushed for a shift back to physical workplaces by targeting employees’ bonuses.

Unsurprisingly, this has left many employees disgruntled. In fact, companies have started providing more benefits in addition to employees’ basic wage, in a bid to attract talent. These range from private pension schemes and home loan benefits to discounts and gym memberships.

Additionally, International Workplace Group’s survey also found that three in five (62 per cent) of business leaders stated that they are now dividing their working time between a central office, local flexible workspace or office, and home. This indicates a growing preference for decentralised work environments.

Just two per cent of respondents said that they spend most of their time working from home.

Three quarters of business leaders stated that since the adoption of hybrid working, their company culture has improved. 77 per cent also noted widespread improvement in employee engagement, while 75 per cent felt there was more efficient collaboration between teams and colleagues.

73 per cent agreed that hybrid work arrangements have enabled them to attract and hire the best talent. 71 per cent of CEOs stated that allowing employees to have greater autonomy over when and where they work has allowed them to consider and subsequently offer roles to a more diverse range of candidates.

Interestingly, out of the CEOs questioned, 74 per cent of business leaders stated that returning to the office full time “is not a priority” for their business moving forward, particularly since staff retention could be impacted and hybrid work has positively impacted productivity.

65 per cent of respondents remarked that they would end up losing talented employees if they insisted on their workforce to be present in a central office every day.

Additionally, 94 per cent stated that their business had invested in new technology to improve the hybrid experience.

Related

MedTech World returns to Malta, bringing global healthcare investors and innovators together

4 November 2026
by MaltaCEOs

For companies supplying Malta’s healthcare market, access to new manufacturers and technologies can shape their next phase of growth.

Jake Schembri becomes Head of Strategic Partnerships at Merqury Cybersecurity 

4 November 2026
by Tim Diacono

Jake Schembri says he will focus on bringing Merqury's technology into more deployments.

Sandro Lauri appointed CEO at Energy and Water Agency

4 November 2026
by Kevin Schembri Orland

He brings extensive experience in energy policy, strategic planning and the development of national energy frameworks.

Andre Spiteri appointed Director – Malta Greenfield Development at Vantive Health

4 November 2026
by Nicole Zammit

Vantive Health is a global healthcare compnay focused on providing therapies for patients with acute and chronic organ conditions.